FindTrial
Sign In

An innovative platform for precision medicine of cardiovascular diseases based on omics and clinical characteristics

An innovative platform for precision medicine of cardiovascular diseases based on omics and clinical characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026498
Enrollment
Unknown
Registered
2019-10-12
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension-Coronary Heart Disease-Heart Failure

Interventions

Case series:NA

Sponsors

Shunde Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Those who in the local area, aged >=18 years,have cardiovascular diseases, such as hypertension, coronary heart disease, heart failure, congenital heart disease, etc., and have signed informed consent.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
all-cause mortality;—

Secondary

MeasureTime frame
Heart failure rehospitalization;Major adverse cardiac outcome;cardiovascular mortality;—

Countries

China

Contacts

Public ContactYuli Huang

Shunde Hospital, Southern Medical University

hyuli821@163.com+86 15099882157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026